600222 太龙药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.1623.7743.2052.766-4.470
总资产报酬率 ROA (%)0.0711.6831.4301.213-1.954
投入资产回报率 ROIC (%)0.0982.2971.9701.775-2.504

边际利润分析
销售毛利率 (%)26.21728.00325.59327.28224.077
营业利润率 (%)0.7134.4211.8402.134-3.610
息税前利润/营业总收入 (%)4.9517.7354.7734.662-0.984
净利润/营业总收入 (%)0.6613.7472.7552.166-3.864

收益指标分析
经营活动净收益/利润总额(%)109.199123.72356.06879.25640.946
价值变动净收益/利润总额(%)69.1101.60530.433-14.95213.385
营业外收支净额/利润总额(%)0.026-0.262-1.839-2.80314.568

偿债能力分析
流动比率 (X)1.2591.1431.0621.2081.177
速动比率 (X)0.9930.9540.8570.9320.916
资产负债率 (%)54.72054.34553.40054.61455.248
带息债务/全部投入资本 (%)39.81934.88939.08130.32733.421
股东权益/带息债务 (%)146.337181.689149.609213.566190.278
股东权益/负债合计 (%)79.87181.07084.50380.80578.814
利息保障倍数 (X)1.1682.3261.6091.803-0.304

营运能力分析
应收账款周转天数 (天)262.221195.766153.986126.000112.925
存货周转天数 (天)142.193102.619102.572108.344100.644